Safety of sugammadex for reversal of neuromuscular block: a post-marketing study based on the World Health Organization pharmacovigilance database
Running title: Sugammadex safety for block reversal
Qiang Lyu1,2†, Pei Ye3†, Hewei Zhang4†, Xiaofei Ye4, Yi Zheng4, Jinfang Xu4, Xiao Chen4, Chenxin Chen4, Xiaojing Guo4*
1Basic Medical College, Naval Medical University, Shanghai, China.
292608 Militang Hospital of PLA, Shanghai, China
3Department of Anaesthesiology, Huadong Hospital Affiliated to Fudan University, Shanghai, China
4Department of Health Statistics, Faculty of Health Service, Naval Medical University, Shanghai, China
Qiang Lyu, Pei Ye, and Hewei Zhang contributed equally to this work.
*Correspondence: guoxiaojing1003@163.com